Reactive oxygen species production is involved in quercetin-induced apoptosis in human hepatoma cells

Nutrition and Cancer

Volumn 55, Issue 2, 2006, Pages 201-209

  Chang, Yuh Fang ^a   Chi, N Wen ^a,b   Wang, Jane Jen ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; PACLITAXEL; QUERCETIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRAIN HA22T; CELL STRAIN VGH; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER CELL CARCINOMA; OXIDATIVE STRESS;

ANNEXIN A5; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; MALONDIALDEHYDE; PACLITAXEL; QUERCETIN; REACTIVE OXYGEN SPECIES;

EID: 33750892350     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5502_12     Document Type: Article

References (34)

1. Scharf G, Prustomersky S, Kanasmuller S, Schulte-Hermann R, and Huber WW: Enhancement of glutathione and g-glutamylcysteine synthetase, the rate limiting enzyme of glutathione synthesis, by chemoprotective plant-derived food and beverage components in the human hepatoma cell line HepG2. Nutr Cancer 45, 74-83, 2003.
2. Kang TB and Liang NC: Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54, 1013-1018, 1997.
3. Mouria M, Gukovskaya AS, Jung Y, Buechler P, Hines OJ, et al.: Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer 98, 761-769, 2002.
4. Wei YQ, Zhao X, Kariya Y, Flukata H, Teshigawara K, et al.: Induction of apotosis by quercetin: involvement of heat shock protein. Cancer Res 54, 4952-4957, 1994.
5. Chi CW, Chang YF, Ou YR, Hsieh CC, Lui WY, et al.: Effect of quercetin on the in vitro and in vivo growth of mouse hepatoma cells. Oncol Rep 4, 1021-1024, 1997.
6. Zhou Y, Hileman EO, Plunkett W, Keating MJ, and Huang P: Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 101, 4098-4104, 2003.
7. Halliwell B and Gutteridge J: Free radicals in biology and medicine, 3rd ed. New York: Oxford University Press, 1999.
8. Buttke TM and Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol Today 15, 7-10, 1994.
9. Raha S and Robinson BH: Mitochondria oxygen free radicals, and apoptosis. Am J Med Genet 106, 62-70, 2001.
10. Gaspar J, Rodrigues A, Laires A, Silva F, Costa S, et al.: On the mechanisms of genotoxicity and metabolism of quercetin. Mutagenesis 9, 445-449, 1994.
11. Ochiai M, Nagao M, Wakabayashi K, and Sugimura T: Superoxide dismutase acts as an enhancing factor for quercetin mutagenesis in rat-liver cytosol by preventing its decomposition. Mutat Res 129, 19-24, 1984.
12. Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, and Segura-Aguilar J: Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26, 107-116, 1999.
13. Bokemeyer C, Hartmann JT, Kuczyk MA, Truss MC, Beyer J, et al.: The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors. World J Urol 14, 354-359, 1996.
14. Rowinsky EK: Paclitaxel pharmacology and other tumor types. Semin Oncol 24, 11-12, 1997.
15. Varbiro G, Veres B, Gallyas F, and Sumegi B Jr: Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med 31, 548-558, 2001.
16. Lin HL, Liu TY, Chau GY, Lui WY, and Chi CW: Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 89, 983-994, 2000.
17. Chao Y, Chan WK, Birkhofer MJ, Hu OY, Wang SS, et al: Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer 78, 34-39, 1998.
18. Carter WO, Narayanan PK, and Robinson JP: Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 55, 253-258, 1994.
19. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN, et al.: Lipoperoxides in plasma as measured by lipid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33, 214-220, 1987.
20. Ramanathan B, Jan KY, Chen CH, Hour TC, Yu HJ, et al.: Resistance to Paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res 65, 8455-8460, 2005.
21. Kang TB and Liang NC: Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54, 1013-1018, 1997.
22. Ogawa W, Hosomi Y, and Roth RA: Activation of protein kinase C stimulates the tyrosine phosphorylation and guanosine triphosphatase- activating protein association of p 60 in rat hepatoma cells. Endocrinol 136, 476-481, 1995.
23. Mertens-Talcott SU, Talcott ST, and Percival SS: Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. Nutr Cancer 133, 2669-2674, 2003.
24. Yoshida M, Yamamoto M, and Nikaido T: Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 52, 6676-6681, 1992.
25. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, et al.: The effect of quercetin on cell cycle progression and growth of human gastric cancer cell. FEBS Lett 260, 10-13, 1990.
26. Sahu SC and Gray GC: Pro-oxidant activity of flavonoids: effects of glutathione and glutathione S-transferase in isolated rat liver nuclei. Cancer Lett 104, 193-196, 1996.
27. Polydoro M, de Souza KCB, Andrades ME, Da Silva EG, Bonatto F, et al.: Antioxidant, a pro-oxidant and cytotoxic effects of Achyrocline satureioides extracts. Life Sci 74, 2815-2826, 2004.
28. Rohrdanz E, Bittner A, Tran-Thi QH, and Kahl R: The effect of quercetin on the mRNA expression of different antioxidant enzymes in hepatoma cells. Arch Toxicol 77, 506-510, 2003.
29. Chen J, Ou YX, Da WM, and Kang JH: Coadjustment of quercetin and hydrogen peroxide: the role of ROS in the cytotoxicity of quercetin. Pharmazie 59, 155-158, 2004.
30. Sahu SC and Washington MC: Quercetin-induced lipid peroxidation and DNA damage in isolated rat-liver nuclei. Cancer Lett 58, 75-79, 1991.
31. Zhang K, Yang EB, Tang WY, Wong KP, and Mack P: Inhibition of glutathione reductase by plant polyphenols. Biochem Pharmacol 54, 1047-1053, 1997.
32. Watjen W, Michels G, Steffan B, Niering P, Chovolou Y, et al.: Low concentrations of flavonoids are protective in rat HA11E cells whereas high concentrations cause DNA damage and apoptosis. J Nutr 135, 525-531, 2005.
33. Makris DP and Rossiter JT: Quercetin and rutin (quercetin 3-O-rhamnosylglucoside) thermal degradation in aqueous media under alkaline conditions. In: Functional Foods II: Claims and Evidence. Buttriss J and Saltmarsh M (eds). Cambridge, UK: Royal Society of Chemistry, 2000, pp 216-238.
34. Son YO, Lee KY, Kook SH, Lee JC, Kim JG, et al.: Selective effects of quercetin on the cell growth and antioxidant defense system in normal versus transformed mouse hepatic cell lines. Eur J Pharm 502, 195-204, 2004.